PharmaKure granted MHRA Scientific Trial Authorisation (CTA) for PK051 for the therapy of gentle cognitive impairment as a consequence of Alzheimer’s Illness
PharmaKure, a scientific stage pharmaceutical firm creating precision medicines for Alzheimer’s Illness and different neurodegenerative [...]